GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
10.6338 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
10.3364 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
10.2507 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, HTR2A, HTR2B |
9.8336 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.34658 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
8.46953 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, TNKS, TNKS2, XDH |
7.46233 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.25164 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19778 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19778 |
[BP] GO:0006939 |
None
|
ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
7.15096 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
7.15096 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
7.15096 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.00103 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A |
6.99966 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, HSD11B2, HTR5A, TYR |
6.99966 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
6.99966 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
6.98397 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.71862 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.49994 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
6.47521 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.3606 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.30939 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
6.16016 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
6.08726 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, GBA2, HTR1A, TYR |
6.03404 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
5.97568 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
5.95148 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
5.94085 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
5.53875 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
5.51458 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, DRD1, DRD2, DRD3, HTR2A, HTR2B, TNKS, TNKS2 |
5.47553 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
5.4273 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
5.4273 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, HSD11B2, HSD17B2, HTR5A, TYR |
5.42421 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, HSD11B2, HSD17B2, HTR5A, TYR |
5.37085 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, SIGMAR1, TNKS2, TYR |
5.37085 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
5.37085 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
5.37085 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.211 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
5.19429 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.16825 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.10477 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
5.05279 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
5.02123 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, BCL2, CA2, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, HTR5A, SIGMAR1, TYR |
4.89876 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALPL, BCL2, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, TNKS2, TYR |
4.8915 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
4.83742 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP4, HSD11B2, HSD17B2, HTR5A, TYR |
4.71459 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
4.69923 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, HTR1A, HTR2A, HTR2B, XDH |
4.67456 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.6219 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.6219 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.54094 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
4.48874 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP4, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR5A, TYR |
4.48874 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B |
4.4743 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FUT7, GBA2, HTR2B, TYR, XDH |
4.38418 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.36178 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, TNKS, TNKS2 |
4.36178 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.36178 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.36178 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, TYR |
4.30011 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3 |
4.20946 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.19004 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, HSD11B2, HTR5A |
4.16184 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
4.14099 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PTPN1, SIGMAR1, TNKS, TNKS2 |
4.08363 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.96034 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.96034 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.88613 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
3.80976 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
3.75789 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
3.69451 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.69451 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD2, DRD3, ESR1, F3, HTR1A, HTR2A, HTR2B |
3.67562 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.66885 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3 |
3.64247 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.63425 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.63425 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, PTPN1, TNKS, TNKS2, TYR, XDH |
3.62102 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2 |
3.62102 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, DRD2, HTR2A |
3.5608 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.54723 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.53558 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.49501 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.48365 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, HTR1A, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
3.4369 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP4, HTR2A, HTR2B |
3.41928 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.39941 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.36258 |
[BP] GO:0006936 |
None
|
ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
3.36258 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.36258 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, HTR1A, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
3.36088 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.34676 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3 |
3.34281 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, BCL2, CYP1B1, DRD2, F10, F3, HTR2A, HTR2B, HTR6, PTPN1, XDH |
3.29198 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.27851 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, HSD11B2, HTR5A |
3.2671 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, HTR1A, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
3.26646 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.25577 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, DRD2, DRD3, TNKS, TNKS2 |
3.24155 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP4, HTR1A, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
3.18534 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.17322 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, TYR |
3.12174 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.09311 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, HTR2A, HTR2B, HTR6, PTPN1, TNKS, TNKS2, XDH |
3.0596 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.05548 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.05548 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.05548 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
3.05173 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.02034 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.02034 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3 |
3.00233 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.9783 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.9783 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.9783 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, HTR1A, HTR2A |
2.95912 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.8924 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.88979 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.84935 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.83165 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP4, GBA2 |
2.82405 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.82229 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.80301 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.76828 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, PTPN1, TYR |
2.75525 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.75004 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.73132 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.72218 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, DRD2, DRD3, HTR2A |
2.71855 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.69054 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.69054 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.69054 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.69054 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, CHRM3, DRD2, F10, F3, XDH |
2.68056 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR2B, PTPN1, TNKS, TNKS2, TYR, XDH |
2.67546 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.67409 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3 |
2.67379 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.62996 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A |
2.60059 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3 |
2.58408 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.58408 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.58408 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58408 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, TYR |
2.58408 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP4, HTR2A, HTR2B |
2.58408 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.58408 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.58408 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.58408 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.5839 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, BCL2, CA2, CA7, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, PTPN1 |
2.5705 |
[BP] GO:0019229 |
None
|
ADRA1A, CHRM1, CHRM3, HTR2A |
2.5611 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.55885 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.53345 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.53345 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.52102 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.51639 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.46562 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.4409 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.42638 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.42638 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, HTR2A, HTR2B, HTR6, PTPN1, XDH |
2.42481 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, TNKS2 |
2.3965 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.37683 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37683 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.34352 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.34352 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34352 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4 |
2.32189 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A |
2.30604 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.29542 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.28997 |
[BP] GO:0051302 |
None
|
CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.28263 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A |
2.27734 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.21215 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, HSD11B2 |
2.20491 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.20372 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.20372 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.19537 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.17197 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B |
2.16934 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.16934 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.16934 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.16934 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.16934 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.16934 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.16934 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.16934 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.16934 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.16934 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP4, FUT7, GBA2 |
2.14439 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.14314 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.14314 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, BCL2, CA2, CDK6, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, TNKS2, XDH |
2.14314 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
2.12378 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, HSD11B2 |
2.10564 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.10564 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, HTR1A, TYR |
2.08924 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3 |
2.08924 |
[BP] GO:0051781 |
None
|
CDC25B, DRD2, DRD3, HTR2B |
2.08902 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.08131 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.07792 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.07792 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.07792 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A |
2.07792 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3 |
2.05428 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.05263 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.03634 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03634 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.03634 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.03634 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.03634 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A |
2.0175 |
[BP] GO:0050890 |
None
|
ADORA1, CHRM1, DRD1, DRD2, DRD3, HTR2A |
2.00883 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A |
2.0046 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
6.01594 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PTPN1, SIGMAR1, TYR |
5.19429 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PTPN1, SIGMAR1, TNKS, TNKS2, TYR |
4.83368 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.22048 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.44126 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, GBA2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PTPN1 |
3.37263 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, HTR2A, SIGMAR1 |
3.28529 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, F10, F3, FUT7, GBA2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, TYR |
3.03148 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, SIGMAR1 |
2.8924 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, F10, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1, SIGMAR1 |
2.78598 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.67409 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.58408 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6 |
2.5244 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.33633 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6 |
2.19119 |
[CC] GO:0045202 |
None
|
ACHE, CHRM1, CHRM2, CHRM3, CHRM5, HTR2B |
2.08704 |
[CC] GO:0098793 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, DRD2 |
2.04234 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
14.8559 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
13.3251 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
13.2378 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.4934 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
10.4531 |
[MF] GO:0046914 |
transition metal ion binding
|
AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, PTPN1, TNKS, TYR, XDH |
7.8734 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
7.77185 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
7.42149 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19778 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19778 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.15096 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.15096 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
7.0426 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRM3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.99966 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.85417 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
6.85417 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.71862 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, PTPN1, TNKS, TNKS2, TYR, XDH |
6.68045 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
6.41445 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.02593 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.64979 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.63643 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP4, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, PTPN1, TNKS, TNKS2, TYR, XDH |
5.53875 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
5.53494 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
5.53494 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.42421 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.33416 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTPN1, TNKS, TNKS2, TYR, XDH |
4.66457 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.36761 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.36178 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.36178 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
4.16184 |
[MF] GO:0005506 |
iron ion binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
4.09146 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.71044 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.69451 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.64528 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.59798 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.54723 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, PTPN1, TNKS |
3.34676 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, HTR2A, HTR2B, SIGMAR1 |
3.17322 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.14625 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
3.09756 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.05548 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.98515 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.9783 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.9783 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B2, HSD17B1, XDH |
2.92414 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.83165 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.83165 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.75332 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.58408 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.58408 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.47544 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.34352 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.34352 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, PTPN1 |
2.30604 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.24504 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16934 |
[MF] GO:0042578 |
None
|
ADORA1, ALPL, CDC25B, CHRM1, CHRM3, CHRM5, PTPN1 |
2.14871 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03634 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03634 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6 |
2.01636 |
[MF] GO:0008289 |
lipid binding
|
ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B1 |
2.01242 |